跳至主要内容
临床试验/NCT05528302
NCT05528302进行中(未招募)不适用

Technology Assisted and Remotely Delivered Cognitive Behavioural Therapy Intervention for Anxiety in People Living With Cognitive Impairment: Randomised Controlled Trial

The University of Queensland5 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2023年2月20日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
70
试验地点
5
主要终点
Change in anxiety

研究概览

简要总结

This study is a randomized controlled trial (RCT) of a remotely-delivered, technology-assisted psychotherapy program, supported by an innovative software platform for people with cognitive impairment experiencing anxiety.

详细描述

Despite harmful health and economic consequences, anxiety is a vexing issue in persons with cognitive impairment with inadequate treatment options. What is needed currently is a digital technology option for treating anxiety in persons with cognitive impairment that can be rigorously evaluated and implemented. The objective of the study is to test the efficacy of a newly modified psychotherapy package (Tech-CBT), which incorporates Cognitive Behaviour Therapy (CBT) methods, assisted with technology and telehealth for persons with cognitive impairment experiencing anxiety. This project will also investigate the cost-effectiveness, usability and acceptability of Tech-CBT to enhance delivery of anxiety treatment for people with cognitive impairment. A process evaluation will inform its implementation in the community and memory clinics, and will recommend a strategic translational roadmap to enhance delivery of anxiety treatment in health services with a broad reach.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Persons aged 18 years or over
  • Persons with a diagnosis of mild cognitive impairment (MCI) or dementia of any aetiology based on a previous diagnosis by a clinician or scoring above threshold (≤32; MCI ≤32 and dementia ≤27) for cognitive impairment in the Modified Telephone Interview for Cognitive Impairment (TICS-M).
  • Screening positive for anxiety (scoring ≥9 on Geriatric Anxiety Inventory, GAI), and/or subjective complaints of anxiety and/ or clinician diagnosis of a current anxiety disorder and screening positive for anxiety using the Rating Anxiety in Dementia scale (scoring ≥11 on RAID)

排除标准

  • Persons with severe dementia
  • Persons unable to communicate or complete questionnaires
  • Persons who have a current risk of suicide within the last month as determined by the study clinical expert team.
  • Persons with major depression as the primary complaint without reported symptoms of anxiety
  • Persons with comorbid psychiatric conditions

研究组 & 干预措施

Tech-CBT intervention

Experimental

Participants allocated to the Tech-CBT intervention group will attend six telehealth videoconferencing sessions - 1 session per week over 6 weeks. Each session will last between 60 to 90 minutes and will be facilitated by a trained therapist. During each session, the participant will learn and practice different psychotherapy techniques. The participant will be encouraged to practice these skills between sessions with the technology provided, either on their own or with the help of their support person.

干预措施: Tech-CBT intervention (Other)

Control

No Intervention

Participants allocated to the Control group will receive usual care (i.e., no treatment for anxiety) and a mid-point check-in phone call/video call/email (depending on their preference) from the study team approximately 3 weeks after completing the initial questionnaires. This mid-point check-in is to identify whether there have been any changes to their usual care.

结局指标

主要结局

Change in anxiety

时间窗: Post-assessment (primary), 3 month follow-up and 6 month follow-up. Score ranging between 0 to 54 (lower score indicates better outcomes).

Change from baseline in anxiety as measured by the Rating Anxiety in Dementia Scale (RAID).

次要结局

  • Change in quality of life(Post-assessment (~week 8), 3 month follow-up and 6 month follow-up. Score ranging between 0 to 52 (higher score indicates better outcomes).)
  • Change in anxiety(Post-assessment (~week 8), 3 month follow-up and 6 month follow-up. Score ranging between 0 to 20 (lower score indicates better outcomes).)
  • Change in worry(Post-assessment (~week 8), 3 month follow-up and 6 month follow-up. Score ranging between 8 to 40 (lower score indicates better outcomes).)
  • Change in stress(Post-assessment (~week 8), 3 month follow-up and 6 month follow-up. Score ranging between 0 to 56 (lower score indicates better outcomes).)
  • Change in depressive symptoms(Post-assessment (~week 8), 3 month follow-up and 6 month follow-up. Score ranging between 0 to 15 (lower score indicates better outcomes).)
  • Change in carer burden(Post-assessment (~week 8), 3 month follow-up and 6 month follow-up. Score ranging between 0 to 88 (lower score indicates better outcomes).)
  • Change in carer quality of life(Post-assessment (~week 8), 3 month follow-up and 6 month follow-up. Score ranging between 20 to 99 (lower score indicates better outcomes).)
  • Change in carer depression and anxiety symptoms(Post-assessment (~week 8). Score ranging between 0 to 126 (lower score indicates better outcomes).)
  • For people living with Parkinson's Disease, a change in Parkinsonism symptomology(Post-assessment (~week 8), 3 month follow-up and 6 month follow-up. Score ranging between 0 to 3500 (lower score indicates better outcomes).)
  • For people living with Parkinson's Disease, a change in anxiety(Post-assessment (~week 8). Score ranging between 0 to 40 (lower score indicates better outcomes).)
  • For people living with Parkinson's Disease, a change in anxiety(Post-assessment (~week 8). Score ranging between 0 to 48 (lower score indicates better outcomes).)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (5)

Loading locations...

相似试验